Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 218783
Company: RISING
Company: RISING
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| DICHLORPHENAMIDE | DICHLORPHENAMIDE | 50MG | TABLET;ORAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 11/18/2025 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
DICHLORPHENAMIDE
TABLET;ORAL; 50MG
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| DICHLORPHENAMIDE | DICHLORPHENAMIDE | 50MG | TABLET;ORAL | Prescription | No | AB | 218783 | RISING |
| KEVEYIS | DICHLORPHENAMIDE | 50MG | TABLET;ORAL | Prescription | Yes | AB | 011366 | XERIS |
| ORMALVI | DICHLORPHENAMIDE | 50MG | TABLET;ORAL | Prescription | No | AB | 215924 | TORRENT |